Case-Control Study of Fetal Microchimerism and Breast Cancer
Open Access
- 5 March 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (3), e1706
- https://doi.org/10.1371/journal.pone.0001706
Abstract
Prior pregnancy is known to protect against development of breast cancer. Recent studies have demonstrated that pregnancy has the capacity to establish small numbers of immunologically active fetal-derived cells in the mother, a phenomenon known as fetal microchimerism (FMc). We asked whether presence of FMc, routinely acquired during pregnancy, is a protective factor for breast cancer. DNA extracts from peripheral blood specimens were obtained from a population-based case-control study of risk factors for breast cancer in women 21 to 45 years old. Specimens were tested with quantitative PCR for presence and concentrations of male DNA presumed to derive from prior pregnancies with a male fetus. Odds ratios (OR) and 95% confidence intervals (CI) were estimated with consideration of multiple established reproductive and environmental risk factors for breast cancer. FMc results were generated on 99 parous women, 54 with primary invasive breast cancer and 45 general population controls. FMc prevalence was 56% (25/45) and 26% (14/54) in controls and cases, respectively. Women harboring FMc were less likely to have had breast cancer (OR = 0.29, 95% CI 0.11–0.83; p = 0.02, adjusting for age, number of children, birth of a son, history of miscarriage, and total DNA tested). In addition, FMc concentrations were higher in controls versus cases (p = 0.01). Median concentrations were 2 (0–78) and 0 (0–374) fetal genomes/106 maternal genomes in controls and cases, respectively. Results suggest that the enigma of why some parous women are not afforded protection from breast cancer by pregnancy might in part be explained by differences in FMc. Mechanistic studies of FMc-derived protection against breast cancer are warranted.Keywords
This publication has 19 references indexed in Scilit:
- Fetal Microchimerism in Women with Breast CancerCancer Research, 2007
- Characterization ofBRCA1andBRCA2Mutations in a Large United States SampleJournal of Clinical Oncology, 2006
- Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative ConditioningClinical Cancer Research, 2004
- Quantification of maternal microchimerism by HLA‐specific real‐time polymerase chain reaction: Studies of healthy women and women with sclerodermaArthritis & Rheumatism, 2004
- Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaThe Lancet, 1998
- The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancerJournal of Clinical Epidemiology, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Parity and Susceptibility to CancerPublished by Wiley ,1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseThe New England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsThe New England Journal of Medicine, 1979